NCT02748590View on ClinicalTrials.gov

Evaluation of Sacral Neuromodulation (SNM) in the Treatment of Active Ulcerative Colitis (PRIMICISTIM)

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Active Ulcerative Colitis
Interventions
DEVICE

InterStim II Neurostimulator Model 3058

The neuromodulation will be carried out according to the usual protocol: Hospitalization for the establishment of percutaneous electrode in the operating room under general anesthesia with fluoroscopic control. The pacemaker startup will be performed within 12h after surgery

Trial Locations (1)

44000

CHU de Nantes, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT02748590 - Evaluation of Sacral Neuromodulation (SNM) in the Treatment of Active Ulcerative Colitis (PRIMICISTIM) | Biotech Hunter | Biotech Hunter